应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PDLI PDL BioPharma
退市 12-30 16:00:00 EST
2.47
+0.00
0.00%
最高
2.47
最低
2.47
成交量
0.00
今开
2.47
昨收
2.47
日振幅
0.00%
总市值
2.82亿
流通市值
1.99亿
总股本
1.14亿
成交额
0.00
换手率
0.00%
流通股本
8,065万
市净率
0.67
ROE
-7.36%
每股收益
-1.32
52周最高
3.86
52周最低
2.09
市盈率
-1.87
股息
0.20
股息收益率
0.08
ROA
-4.10%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
PDL BioPharma
所属市场:
NASDAQ
上市日期:
1992-01-28
主营业务:
PDL BioPharma, Inc.成立于1986年,总部设在内华达州的Incline Village。PDL BioPharma管理专利和特许权资产组合,主要包括其产品Queen等抗体人源化的专利,并有各种生物技术和制药公司的许可协议。 PDL率先单克隆抗体的人源化,并使新一代的癌症和其接收显著费收入免疫性疾病靶向治疗的发现。 PDL目前专注于知识产权资产管理,以获取新的创收资产和股东价值最大化。
发行价格:
--
{"stockData":{"symbol":"PDLI","market":"US","secType":"STK","nameCN":"PDL BioPharma","latestPrice":2.47,"timestamp":1609362000000,"preClose":2.47,"halted":4,"volume":0,"delay":0,"floatShares":80650155,"shares":113982229,"eps":-1.324007,"marketStatus":"退市","change":0,"latestTime":"12-30 16:00:00 EST","open":2.47,"high":2.47,"low":2.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.324007,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746518400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":696574800000,"exchange":"NASDAQ","adjPreClose":2.47,"volumeRatio":0},"requestUrl":"/m/hq/s/PDLI","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.pdl.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PDL BioPharma, Inc.成立于1986年,总部设在内华达州的Incline Village。PDL BioPharma管理专利和特许权资产组合,主要包括其产品Queen等抗体人源化的专利,并有各种生物技术和制药公司的许可协议。 PDL率先单克隆抗体的人源化,并使新一代的癌症和其接收显著费收入免疫性疾病靶向治疗的发现。 PDL目前专注于知识产权资产管理,以获取新的创收资产和股东价值最大化。","yearOnYearQuotes":[{"month":1,"riseRate":0.464286,"avgChangeRate":-0.001541},{"month":2,"riseRate":0.413793,"avgChangeRate":0.040867},{"month":3,"riseRate":0.482759,"avgChangeRate":-0.044189},{"month":4,"riseRate":0.62069,"avgChangeRate":0.058288},{"month":5,"riseRate":0.482759,"avgChangeRate":-0.009972},{"month":6,"riseRate":0.517241,"avgChangeRate":0.009707},{"month":7,"riseRate":0.517241,"avgChangeRate":-0.022968},{"month":8,"riseRate":0.551724,"avgChangeRate":0.034583},{"month":9,"riseRate":0.551724,"avgChangeRate":0.048828},{"month":10,"riseRate":0.482759,"avgChangeRate":0.04805},{"month":11,"riseRate":0.517241,"avgChangeRate":0.005751},{"month":12,"riseRate":0.448276,"avgChangeRate":0.035435}],"exchange":"NASDAQ","name":"PDL BioPharma","nameEN":"PDL BioPharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PDL BioPharma(PDLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PDL BioPharma(PDLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PDL BioPharma,PDLI,PDL BioPharma股票,PDL BioPharma股票老虎,PDL BioPharma股票老虎国际,PDL BioPharma行情,PDL BioPharma股票行情,PDL BioPharma股价,PDL BioPharma股市,PDL BioPharma股票价格,PDL BioPharma股票交易,PDL BioPharma股票购买,PDL BioPharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PDL BioPharma(PDLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PDL BioPharma(PDLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}